68 records found.
Jun 11, 2018
Correvio Provides U.S. Regulatory Update for BRINAVESS
Jun 06, 2018
CardioNXT Announces Enrollment Completion of RADAR Clinical Trial
May 24, 2018
New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation
May 17, 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China
May 16, 2018
Greater Burden of Atrial Fibrillation Linked to Higher Stroke Risk
May 09, 2018
CardioFocus Announces Successful Live Case Featuring HeartLight® X3 System
May 09, 2018
Bardy Diagnostics(TM) Announces Validation of AI-Enabled Automatic Screening Technology for Atrial Fibrillation
May 08, 2018
First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States
May 08, 2018
NRG® Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
May 08, 2018
Heart Rhythm Society Kicks Off Annual Scientific Sessions In Boston To Unveil Scientific Advances And Innovations In Cardiac Arrhythmia Care
May 08, 2018
New Research Demonstrates Online ECG Monitoring is More Effective than Offline Holter and Patch Methods to Detect Paroxysmal Arrhythmia
May 07, 2018
Biosense Webster, Inc. Launches Sheath Designed To Reduce Radiation Exposure And Improve Ablation Procedure Efficiency
May 07, 2018
Affera's Novel Technology For Cardiac Arrhythmia Treatment To Be Featured In 8 Scientific Sessions At The 2018 Heart Rhythm Society Meeting
May 07, 2018
CardioFocus® Announces FDA Approval Of The Next-Generation HeartLight® Excalibur Balloon(TM) Designed For The Treatment Of Paroxysmal Atrial Fibrillation*
May 07, 2018
Bardy Diagnostics(TM) Announces Results of Head-to-Head Comparison of Patch-Based Arrhythmia Monitors
May 02, 2018
Biosense Webster, Inc. Launches Study To Evaluate Novel High Power, Short Duration Modality For Treatment Of Atrial Fibrillation
May 02, 2018
New Study Examines Online Vs Offline ECG Monitoring to Detect Difficult-to-Diagnose Arrhythmia
Apr 17, 2018
FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa
Apr 17, 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®
Apr 09, 2018
Houston Methodist The Woodlands Hospital is first hospital in The Woodlands to offer an alternative to long-term warfarin medication to reduce the risk of stroke

Pages